Predictive Ability of the SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery Score II for Long-term Mortality in Patients with Three-vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated with Second-generation Drug-eluting Stents.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26265610)

Published in Chin Med J (Engl) on August 20, 2015

Authors

Ji-Qiang He, Xian-Peng Yu, Cheng Peng, Quan Li, Ya-Wei Luo, Yue-Chun Gao, Xiao-Ling Zhang, Chang-Yan Wu, Hua Zhao, Yu-Chen Zhang, Jing-Hua Liu, Shu-Zheng Lyu, Fang Chen1

Author Affiliations

1: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and Institution of Beijing Heart Lung and Vascular Disease, Beijing 100029, China.

Articles cited by this

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention (2005) 5.16

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet (2010) 4.87

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet (2013) 3.41

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med (2010) 3.27

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J (2012) 2.43

Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation (2010) 2.40

Assessment of the SYNTAX score in the Syntax study. EuroIntervention (2009) 2.24

Coronary stents: current status. J Am Coll Cardiol (2010) 2.01

Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv (2011) 1.75

EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart (2008) 1.63

Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. Eur Heart J (2015) 1.61

Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv (2009) 1.56

Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry. Circ J (2014) 1.52

Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol (2007) 1.32

Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv (2010) 1.31

Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol (2011) 1.23

A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv (2010) 1.19

Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv (2011) 1.18

Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg (2011) 1.07

Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study. Am Heart J (2011) 0.97

Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol (2011) 0.90

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv (2011) 0.89

Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial. EuroIntervention (2013) 0.87

A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv (2011) 0.86

Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention. JACC Cardiovasc Interv (2014) 0.85

Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc Interv (2012) 0.81

Clinical outcomes of second- versus first-generation drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. Arch Med Sci (2014) 0.81

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years. JACC Cardiovasc Interv (2012) 0.80

Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score. JACC Cardiovasc Interv (2013) 0.78

Articles by these authors

(truncated to the top 100)

Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst (2003) 5.09

DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res (2008) 3.66

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature (2013) 3.27

Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol (2004) 3.13

Earliest domestication of common millet (Panicum miliaceum) in East Asia extended to 10,000 years ago. Proc Natl Acad Sci U S A (2009) 2.90

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis (2008) 2.31

Phytoliths analysis for the discrimination of Foxtail millet (Setaria italica) and Common millet (Panicum miliaceum). PLoS One (2009) 2.22

Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res (2008) 2.11

Graphene-based antibacterial paper. ACS Nano (2010) 2.07

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res (2005) 1.98

DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol Ther (2003) 1.96

Involvement of novel autophosphorylation sites in ATM activation. EMBO J (2006) 1.94

An extensive field survey combined with a phylogenetic analysis reveals rapid and widespread invasion of two alien whiteflies in China. PLoS One (2011) 1.91

Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol (2012) 1.81

Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler Thromb Vasc Biol (2004) 1.67

Understanding type 1 diabetes through genetics: advances and prospects. Nat Rev Genet (2011) 1.64

Identification of a potential novel type of influenza virus in Bovine in China. Virus Genes (2014) 1.59

Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus. Behav Brain Res (2007) 1.57

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst (2002) 1.56

Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work. J Dermatol (2010) 1.54

Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano (2011) 1.53

Ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean section: an updated meta-analysis. CNS Neurosci Ther (2012) 1.51

Genetic diversity of novel circular ssDNA viruses in bats in China. J Gen Virol (2011) 1.48

Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials. J Cardiothorac Vasc Anesth (2012) 1.47

Interferon-λs: special immunomodulatory agents and potential therapeutic targets. J Innate Immun (2012) 1.46

Sirolimus-eluting, bioabsorbable polymer-coated constant stent (Cura) in acute ST-elevation myocardial infarction: a clinical and angiographic study (CURAMI Registry). J Invasive Cardiol (2007) 1.43

The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One (2011) 1.43

Sources of water pollution and evolution of water quality in the Wuwei basin of Shiyang river, Northwest China. J Environ Manage (2008) 1.42

Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM. J Biol Chem (2002) 1.41

Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion (2009) 1.40

Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents. Coron Artery Dis (2016) 1.39

Comparison of the sensitivity and specificity of 5 image sets of dual-energy computed tomography for detecting first-pass myocardial perfusion defects compared with positron emission tomography. Medicine (Baltimore) (2014) 1.38

Aligned ZnO/CdTe core-shell nanocable arrays on indium tin oxide: synthesis and photoelectrochemical properties. ACS Nano (2010) 1.35

Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Gene (2013) 1.31

XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis (2003) 1.28

Stiff coatings on compliant biofibers: the cuticle of Mytilus californianus byssal threads. Biochemistry (2009) 1.27

Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control. Mol Cell Biol (2008) 1.26

Genome, functional gene annotation, and nuclear transformation of the heterokont oleaginous alga Nannochloropsis oceanica CCMP1779. PLoS Genet (2012) 1.25

Genetic susceptibility to tobacco-related cancer. Oncogene (2004) 1.23

Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep (2009) 1.20

The role of rapid, local, postsynaptic protein synthesis in learning-related synaptic facilitation in aplysia. Curr Biol (2007) 1.20

Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res (2012) 1.18

8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer (2007) 1.16

An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res (2003) 1.16

Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. PLoS One (2012) 1.15

Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer (2007) 1.15

Metabolic disturbances associated with systemic lupus erythematosus. PLoS One (2012) 1.15

Ligusticum chuanxiong Hort: a review of chemistry and pharmacology. Pharm Biol (2011) 1.12

Tetragonal allotrope of group 14 elements. J Am Chem Soc (2012) 1.12

Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer (2006) 1.11

Puerarin: a review of pharmacological effects. Phytother Res (2013) 1.11

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat (2011) 1.10

Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice. J Neurosci (2003) 1.08

Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol (2011) 1.08

Role of protein kinase C in the induction and maintenance of serotonin-dependent enhancement of the glutamate response in isolated siphon motor neurons of Aplysia californica. J Neurosci (2009) 1.08

Probing the electronic structure of ZnO nanowires by valence electron energy loss spectroscopy. Micron (2006) 1.08

Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus. Neurol Res (2008) 1.07

Four new cycloartane glycosides from Thalictrum fortunei. Chem Pharm Bull (Tokyo) (2006) 1.07

Prevalence of heterotypic tumor/immune cell-in-cell structure in vitro and in vivo leading to formation of aneuploidy. PLoS One (2013) 1.05

An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res (2012) 1.05

Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol Nutr Food Res (2009) 1.04

Isolation and characterization of pyrene and benzo[a]pyrene-degrading Klebsiella pneumonia PL1 and its potential use in bioremediation. Appl Microbiol Biotechnol (2014) 1.04

Effects of intravenous and intrathecal dexmedetomidine in spinal anesthesia: a meta-analysis. CNS Neurosci Ther (2013) 1.04

Analgesic effect and adverse events of dexmedetomidine as additive for pediatric caudal anesthesia: a meta-analysis. Paediatr Anaesth (2014) 1.03

Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One (2011) 1.03

Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. Arch Virol (2010) 1.02

Zinc chromate induces chromosome instability and DNA double strand breaks in human lung cells. Toxicol Appl Pharmacol (2008) 1.02

Preparation and biodistribution of [18F]FP2OP as myocardial perfusion imaging agent for positron emission tomography. Bioorg Med Chem (2009) 1.02

B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med (2012) 1.02

Cloning and characterization of a panel of constitutive promoters for applications in pathway engineering in Saccharomyces cerevisiae. Biotechnol Bioeng (2012) 1.02

Intra-shell luminescence of transition-metal-implanted zinc oxide nanowires. Nanotechnology (2009) 1.01

The ProSeal Laryngeal Mask Airway is more effective than the LMA-Classic in pediatric anesthesia: a meta-analysis. J Clin Anesth (2012) 1.01

Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: Roles of Akt, mTOR, GSK3beta, and PTEN. Free Radic Biol Med (2010) 1.01

Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET. J Nucl Med (2012) 1.00

Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. Nanoscale (2011) 1.00

Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice. Phytomedicine (2008) 0.99

Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer (2009) 0.99

Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer (2010) 0.98

Young Leaf Chlorosis 1, a chloroplast-localized gene required for chlorophyll and lutein accumulation during early leaf development in rice. Planta (2012) 0.98

DPP-mediated TGFbeta signaling regulates juvenile hormone biosynthesis by activating the expression of juvenile hormone acid methyltransferase. Development (2011) 0.98

Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic Biol Med (2006) 0.98

Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Tumour Biol (2012) 0.97

Selenoprotein gene expression in thyroid and pituitary of young pigs is not affected by dietary selenium deficiency or excess. J Nutr (2009) 0.97

CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response. Nucleic Acids Res (2009) 0.97

In silico replication of the genome-wide association results of the Type 1 Diabetes Genetics Consortium. Hum Mol Genet (2010) 0.97

Case of sorafenib-induced thyroid storm. J Clin Oncol (2013) 0.97

QiShenYiQi Pills® prevent cardiac ischemia-reperfusion injury via energy modulation. Int J Cardiol (2012) 0.96

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. J Hepatobiliary Pancreat Surg (2002) 0.96

Neoplastic transformation of human bronchial cells by lead chromate particles. Am J Respir Cell Mol Biol (2007) 0.96

Transvaginal laparoscopically assisted endoscopic cholecystectomy: preliminary clinical results for a series of 43 cases in China. Surg Endosc (2010) 0.96

Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res (2004) 0.96

Anti-hypertensive nutraceuticals and functional foods. J Agric Food Chem (2009) 0.96

Alteration of microbial properties and community structure in soils exposed to napropamide. J Environ Sci (China) (2009) 0.96

MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP. Biomed Res Int (2013) 0.96

Photodynamic therapy of condyloma acuminata in pregnant women. Chin Med J (Engl) (2012) 0.95

Identification and characterization of two novel splicing isoforms of human estrogen-related receptor beta. J Clin Endocrinol Metab (2005) 0.95

An on-line replanning method for head and neck adaptive radiotherapy. Med Phys (2009) 0.95

Automated registration of large deformations for adaptive radiation therapy of prostate cancer. Med Phys (2009) 0.94

The selenium deficiency disease exudative diathesis in chicks is associated with downregulation of seven common selenoprotein genes in liver and muscle. J Nutr (2011) 0.94

Clinical effectiveness of hemipelvic reconstruction using computer-aided custom-made prostheses after resection of malignant pelvic tumors. J Arthroplasty (2011) 0.94